Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Immuron Announces Sales (Unaudited) Of Travelan A$1.5M, Up 13% Prior Quarter, An OTC Immune Supplement Targeting Pathogenic Bacteria And Toxins Produced In The Gastrointestinal Tract

Author: Benzinga Newsdesk | October 15, 2024 05:09am

Global	• September 2024 Quarter AUD$1.5 million up 13% on prior quarter
Australia	• September 2024 Quarter AUD$1.0 million up 3% on prior quarter
North America	• September 2024 Quarter AUD$0.5 million up 48% on prior quarter

Posted In: IMRN